{"title":"长期应用链霉素、对氨基水杨酸钠和异烟肼治疗肺结核","authors":"Joseph Smart, James Gough","doi":"10.1016/S0366-0869(58)80138-0","DOIUrl":null,"url":null,"abstract":"<div><p>The results obtained in a personal series of 75 patients treated with chemotherapy alone (streptomycin, PAS and isoniazid) for at least one year are reported.</p><p>At the end of the observation period 69 patients (92 per cent.) were “quiescent,” 5 were “active” and 1 was dead. No patients relapsed after completing treatment.</p></div>","PeriodicalId":100202,"journal":{"name":"British Journal of Tuberculosis and Diseases of the Chest","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"1958-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0366-0869(58)80138-0","citationCount":"2","resultStr":"{\"title\":\"The treatment of pulmonary tuberculosis with prolonged streptomycin, sodium P-aminosalicylate and isoniazid\",\"authors\":\"Joseph Smart, James Gough\",\"doi\":\"10.1016/S0366-0869(58)80138-0\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p>The results obtained in a personal series of 75 patients treated with chemotherapy alone (streptomycin, PAS and isoniazid) for at least one year are reported.</p><p>At the end of the observation period 69 patients (92 per cent.) were “quiescent,” 5 were “active” and 1 was dead. No patients relapsed after completing treatment.</p></div>\",\"PeriodicalId\":100202,\"journal\":{\"name\":\"British Journal of Tuberculosis and Diseases of the Chest\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"1958-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1016/S0366-0869(58)80138-0\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Tuberculosis and Diseases of the Chest\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0366086958801380\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Tuberculosis and Diseases of the Chest","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0366086958801380","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The treatment of pulmonary tuberculosis with prolonged streptomycin, sodium P-aminosalicylate and isoniazid
The results obtained in a personal series of 75 patients treated with chemotherapy alone (streptomycin, PAS and isoniazid) for at least one year are reported.
At the end of the observation period 69 patients (92 per cent.) were “quiescent,” 5 were “active” and 1 was dead. No patients relapsed after completing treatment.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
